A study of women, by women. We're talking about the Imbokodo trial, which is evaluating an investigational HIV vaccine in sub-Saharan Africa. As the study approaches a key milestone, we sat down with South African physician and scientist Glenda Gray, who's at the helm of the groundbreaking trial.
In time for summer, we went to the pros—a dermatologist, a marine biologist and a skincare scientist—to get the latest study-backed news you need to know.
As a teenager, Wayne Drevets, M.D., had friends who struggled with depression—and who ultimately inspired him to focus his career on helping people with the debilitating disorder.
A visit back to her Kentucky roots with Save the Children brought Joy Marini full circle—and underscored the importance of the work she does with Johnson & Johnson to help children around the globe.
A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
From a clever way to help prep kids for surgery to a baby bottle nipple shaped just like Mom's, these nurses' bright ideas helped them win Johnson & Johnson's first nursing innovation challenge—and a total of $100,000 in grant money.
From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
-
What You're Talking About
-
Fact
Johnson & Johnson was named to the 2019 LinkedIn Top Companies list in the U.S.—plus these three international lists around the world.
